Please login to the form below

Not currently logged in

‘Common Rulebook’ Brexit plans include medicines – but face backlash

Government compromises could be opposed from both sides

MaxCyte gets green light for solid tumour cell therapy

MaxCyteIts first CAR therapy will be tested in patients with ovarian cancer

Daily Brief: Limited NICE recommendation for Fasenra, Urovant takes aim at an IPO, Xtandi expands use

FasenraNews from pharma, biotech and healthcare

GSK sells eczema and psoriasis drug to Dermavant for £250m

GSK - logo on buildingThe British group is selling off assets outside core therapy areas to boost R&D


‘Post-Brexit landscape for EU-wide IP Rights: The Story So Far’

Brexit means pharma must review its intellectual property rights across Europe

The Gallery

A visual showcase of agency work. Track down an agency from the image, track down your competitors' work, search by product or therapy area to pull up, for example, cardiovascular campaigns. Click here for a portfolio of hundreds of campaign visuals – updated regularly – free for you to reference. Agencies – to add your work to The Gallery please contact us.

‘Post-Brexit landscape for EU-wide IP Rights: The Story So Far’

Brexit means pharma must review its intellectual property rights across Europe


Communiqué Awards 2018 - Photo Gallery

View the 2018 Winners and Photo Galleries

Commentary: Roseanne’s racist tweet and Sanofi’s swift and surprising riposte

Alexander Davies considers the remarkable story of how one company broke with pharma convention to speak out on social media

Sanofi Ambien

Healthcare Comms appointments

Cuttsy+Cuttsy appoints new director, Porterhouse Medical adds to team and TBWA\WorldHealth London sees Andy Hayley and Dick Dunford return


Malthus’ orphans

Firms focusing on small, high-profit niches risk falling into a 200-year-old trap

darwins medicine

No results were found

Pharma industry appointments

Destiny Pharma, Silence Therapeutics and Concept Life Sciences add to its teams.

Dave Lemus

The Directory and digital round-up

SOPHiA Genetics acquires IBS, Kyomed becomes KYomed INNOV and launches ePRO, Medtronic unveil diabetes app


Trump attempts The Art of the Deal with pharma

Yet incendiary language, bullying and threats rarely lead to a deal

No results were found

Doing more with less: when ‘client-centricity’ matters most

At a time when companies face continued downward pressure on operational expenditure, doing ‘more with less’ is becoming a fact of life

Angela Mahaney

Featured jobs

Subscribe to our email news alerts


Add my company
Adelphi Research UK

Adelphi Research UK is a healthcare insight partner. We uniquely blend robust market research with a consultancy approach, to guide...

Latest intelligence

GDPR and events. What does the pharma industry need to know?
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...